Stay updated with breaking news from Peripheral Interventions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Late-breaking data demonstrate superior rates of primary patency and statistically significant sustained clinical improvement
Press release content from PR Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Today, Boston Scientific Corporation (NYSE: BSX) announced positive data for the Eluvia™ Drug-Eluting Vascular Stent System (Eluvia stent)...
/PRNewswire/ -- Today, Boston Scientific Corporation (NYSE: BSX) announced positive data for the Eluvia™ Drug-Eluting Vascular Stent System (Eluvia stent)...
/PRNewswire/ -- Today, Boston Scientific (NYSE: BSX) announced positive results for the Ranger™ Drug-Coated Balloon (DCB) during a late-breaking clinical trial...